
Momentum was growing for a fresh look at the safety of Celebrex and
other pain relievers as key researchers, a congressman and European
regulators said they feared such drugs might raise the risk of heart
problems like those blamed on the arthritis medicine Vioxx.
The Food and Drug Administration silenced one of its drug experts who
raised safety concerns weeks before Merck & Co. yanked the
blockbuster drug Vioxx due to increased risks for heart attack and
strokes, the chairman of the Senate Finance Committee said Thursday.
The following editorial appeared in Thursday's Washington Post: